MultiCell Technologies, Inc.

MultiCell Technologies, Inc.

MCET - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$500
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
MultiCell Technologies, Inc.MultiCell Technologies, Inc.-0.1-101%--1114.9
$0.00

Current Fair Value

0% upside

Overvalued by 0% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$500.00
Enterprise Value$278,944.00
Earnings per Share$0
Beta-8.86
Outstanding Shares5,000,948

Return

Return on Equity101.20%ROE
Return on Assets-85.47%
Return on Invested Capital20261.77%

Valuation & Multiples

P/E Ratio-0.1P/E Ratio
PEG0.06PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.0Price to Book Ratio
Enterprise Value to Revenue347.38
Enterprise Value to EBIT-1.11
Enterprise Value to Net Income-1103
Total Debt to Enterprise1
Debt to Equity-1114.9Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About MultiCell Technologies, Inc.

2 employees
CEO: W. Gerald Newmin

MultiCell Technologies, Inc. (MCET) operates as a biopharmaceutical firm, primarily focused on the creation of innovative therapeutic agents and research tools. Their efforts are directed towards addressing a range of medical challenges,...

Questions & Answers